SBILIFE - SBI Life Insurance Company Limited
NSE
->
Financial Services
->
Insurance—Life
Mumbai,
India
Type: Equity
SBILIFE price evolution
SBILIFE
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33024.9 | $44554.1 | $32042.2 | $33709.3 |
| Short term investments | $15771.75 | |||
| Net receivables | $8706.7 | |||
| Inventory | ||||
| Total current assets | $78536.8 | $85397.7 | $76157.4 | $75948.7 |
| Long term investments | $111192.5 | $108050.7 | $100758.2 | $100301.9 |
| Property, plant & equipment | $5250.4 | $5324.6 | $5267.7 | $5346.2 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $2884400.8 | $2690284.2 | $2733369.9 | $2628281.2 |
| Current liabilities | ||||
| Accounts payable | $19316.39 | |||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $44333.3 | $39652.3 | $51297.9 | $55402.9 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $2762240.3 | $2572685.8 | $2617146.8 | $2516293.8 |
| Shareholders' equity | ||||
| Retained earnings | $103940.82 | |||
| Other shareholder equity | $112153.4 | $107593.6 | $106219.4 | $101984.6 |
| Total shareholder equity | $122160.5 | $117598.4 | $116223.1 | $111987.4 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $32042.2 | $27071.53 | $14198.67 | $24173.21 |
| Short term investments | $15771.75 | $7348.73 | $6040.14 | $4205.26 |
| Net receivables | $8706.7 | $11804.39 | $7954.89 | $7857.59 |
| Inventory | ||||
| Total current assets | $76157.4 | $52424.99 | $31952.08 | $40569.48 |
| Long term investments | $100758.2 | $78130.19 | $62239.32 | $53027.14 |
| Property, plant & equipment | $5267.7 | $5453 | $5436.1 | $5542.14 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $2733369.9 | $2268304.39 | $1655800.6 | $1467338.45 |
| Current liabilities | ||||
| Accounts payable | $19316.39 | $17520.33 | $13358.29 | $11683.68 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $51297.9 | $42383.71 | $30221.72 | $37360.1 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $2617146.8 | $2164300.02 | $1568369.76 | $1391574.89 |
| Shareholders' equity | ||||
| Retained earnings | $103940.82 | $90881.59 | $78823.27 | $64601.44 |
| Other shareholder equity | $106219.4 | $3081.47 | -$1407.22 | $1162.12 |
| Total shareholder equity | $116223.1 | $104004.36 | $87430.84 | $75763.56 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $277229 | $48079.1 | $205865.6 | $206727.3 |
| Cost of revenue | $262351.3 | $35804.7 | $187505 | $192704.5 |
| Gross Profit | $14877.7 | $12274.4 | $18360.6 | $14022.8 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $5082.4 | $4859.3 | $4944.2 | $4930.8 |
| Total operating expenses | $272859.4 | $45070.5 | $198614.3 | $202629.7 |
| Operating income | $4369.6 | $3008.6 | $7251.3 | $4097.6 |
| Income from continuing operations | ||||
| EBIT | $4369.6 | $3008.6 | $7251.3 | $4097.6 |
| Income tax expense | $602.1 | $380.1 | $529.8 | $457 |
| Interest expense | ||||
| Net income | ||||
| Net income | $3767.4 | $2628.5 | $6721.5 | $3640.6 |
| Income (for common shares) | $3767.4 | $2628.5 | $6721.5 | $3640.6 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $829573.2 | $821279.86 | $437453.28 | $445409.65 |
| Cost of revenue | $773370.4 | $774978.77 | $390335.66 | $404070.95 |
| Gross Profit | $56202.8 | $46301.09 | $47117.62 | $41338.7 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $19733.5 | $22307.95 | $22559.14 | $19749.28 |
| Total operating expenses | $812704 | $804796.5 | $419465.53 | $428917.41 |
| Operating income | $16869.2 | $16483.35 | $17987.74 | $16492.24 |
| Income from continuing operations | ||||
| EBIT | $16869.2 | $16483.35 | $17987.74 | $16492.24 |
| Income tax expense | $1809.2 | $1841.67 | $3681.06 | $3147.57 |
| Interest expense | -$83.19 | -$84.86 | -$76.71 | |
| Net income | ||||
| Net income | $15059.9 | $14558.49 | $14221.83 | $13267.96 |
| Income (for common shares) | $15059.9 | $14558.49 | $14221.83 | $13267.96 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Net income | $3767.4 | $2628.5 | $6721.5 | $3640.6 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | ||||
| Change in cash and equivalents | ||||
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Net income | $15059.9 | $14558.49 | $14221.83 | $13267.96 |
| Operating activities | ||||
| Depreciation | $617.13 | $900.31 | $916.98 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $218519.4 | $238776.44 | $192985.88 | $134728.62 |
| Investing activities | ||||
| Capital expenditures | -$557.9 | -$1045.21 | -$809.93 | -$1423.88 |
| Investments | -$332508.1 | -$298344.53 | -$250657.65 | -$203349.92 |
| Total cash flows from investing | -$216110 | -$192027.07 | -$169868.97 | -$135528.64 |
| Financing activities | ||||
| Dividends paid | -$2500.1 | -$1999.59 | -$1999.51 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$2310.1 | $26.49 | -$1984.8 | -$2410.62 |
| Effect of exchange rate | -$5.93 | $5.13 | $4.58 | |
| Change in cash and equivalents | $99.2 | $46769.94 | $21137.24 | -$3206.05 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $737.90B |
|---|---|
| EBITDA | N/A |
| EBIT | $18.73B |
| Net Income | $16.76B |
| Revenue Q/Q | 7.91% |
| Revenue Y/Y | -16.89% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 0.61% |
| ROE | 14.32% |
| Debt/Equity | 22.52 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.77 |
| Quick ratio | N/A |